Sunday, December 10, 2023
News Health
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
HealthNews
No Result
View All Result
Home Health News

Real-World Semaglutide Weight Loss Below Trial Levels

September 19, 2023
in Health News
Share on FacebookShare on Twitter


TOPLINE:

  • Real-world data from patients prescribed semaglutide suggest strong but attenuated weight loss after 52 weeks compared with clinical trial findings.

  • Interactions with certain medications and biological factors can be associated with greater or lesser weight loss.

METHODOLOGY:

TAKEAWAY:

  • In the overall population of people who took semaglutide, patients lost an average 4.44% of their initial body weight. Male patients loss less than female patients (3.66% vs 5.08%).

  • The proportions losing ≥5% and ≥10% of their body weight were 41.9% and 18.1%, respectively.

  • At 52 weeks from the start of semaglutide treatment, patients on average lost 4.43% of their initial body weight (3.83% male patients, 4.86% female patients).

  • Patients with diabetes lost 3.86% of initial weight at 52 weeks, as compared with 7.44% of patients who did not have diabetes.

  • Factors significantly associated with losing ≥10% weight 52 weeks after semaglutide exposure were adrenal gland disorders (adjusted odds ratio [aOR], 25.45), linaclotide use (aOR, 14.95), prediabetes (aOR, 2.32), and codeine use (aOR, 2.97).

  • Factors associated with a decreased likelihood of achieving ≥10% weight loss included having diabetes (aOR, 0.44) and receiving a dulaglutide prescription (aOR, 0.26).

IN PRACTICE:

  • “This highlights the challenges of realistically achieving significant weight loss in the real world compared with the clinical trial setting.”

  • “These findings suggest patient-level factors worth considering that may influence weight-loss performance with semaglutide and directions for further research on how to personalize this method of weight-loss therapy.”

SOURCE:

  • Study was conducted by William Powell, of the Department of Biomedical and Health Informatics, University of Missouri–Kansas City School of Medicine, Kansas City, Missouri, and colleagues.

  • The study was published on August 18 in Obesity

LIMITATIONS:

  • Adherence was not assessed.

  • The researchers had no information about patients’ lifestyle practices.

  • The model had low sensitivity, and there was a potential for false negative findings.

  • There were no data for doses >2 mg/wk.

DISCLOSURES:

Miriam E. Tucker is a freelance journalist based in the Washington, DC, area. She is a regular contributor to Medscape. Other work of hers has appeared in the Washington Post, NPR’s Shots blog, and Diabetes Forecast magazine. She can be found on X @MiriamETucker.

For more news, follow Medscape on Facebook, X, Instagram, and YouTube.

Medscape Medical News © 2023 WebMD, LLC

Send comments and news tips to [email protected].

Cite this: Real-World Semaglutide Weight Loss Below Trial Levels – Medscape – Sep 19, 2023.





Source link : https://www.medscape.com/viewarticle/996578?src=rss

Author :

Publish date : 2023-09-19 14:22:34

Copyright for syndicated content belongs to the linked Source.
Previous Post

FXI Inhibitor Cuts Bleeds in Afib; COAPT Extends to Real World; AI Stroke Triage

Next Post

Emerging Risk Factors for Cardiovascular Disease in Women

Related Posts

Health News

Why do people always wait until January to get fit?

December 10, 2023
Health News

In Real World, Patients With Myeloma Have Worse Outcomes

December 9, 2023
Health News

This Test May Guide AML Therapy for Black Pediatric Patients

December 9, 2023
Health News

Less-Frequent Surveillance Mammo Feasible in Older Breast Cancer Survivors

December 9, 2023
Health News

AI and Breast Cancer Screening; Cancer After Treatment for Sickle Cell

December 9, 2023
Health News

Yes, Conversion Therapy Efforts Still Exist in Medical Practice

December 9, 2023
Load More

Why do people always wait until January to get fit?

December 10, 2023

In Real World, Patients With Myeloma Have Worse Outcomes

December 9, 2023

This Test May Guide AML Therapy for Black Pediatric Patients

December 9, 2023

Less-Frequent Surveillance Mammo Feasible in Older Breast Cancer Survivors

December 9, 2023

AI and Breast Cancer Screening; Cancer After Treatment for Sickle Cell

December 9, 2023

Yes, Conversion Therapy Efforts Still Exist in Medical Practice

December 9, 2023

Bilateral Mastectomy Not Tied to Better Survival in BRCA1-Positive Breast Cancer

December 9, 2023

Cannabis can relieve pain short-term, but we still don’t know how

December 9, 2023
Load More

Categories

Archives

December 2023
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Nov    

© 2022 NewsHealth.

No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health

© 2022 NewsHealth.

Go to mobile version

Real-World Semaglutide Weight Loss Below Trial Levels- Real-World Semaglutide Weight Loss Below Trial Levels * Real-World Semaglutide Weight Loss Below Trial Levels | Real-World Semaglutide Weight Loss Below Trial Levels | Real-World Semaglutide Weight Loss Below Trial Levels | Real-World Semaglutide Weight Loss Below Trial Levels | Real-World Semaglutide Weight Loss Below Trial Levels | Real-World Semaglutide Weight Loss Below Trial Levels | Real-World Semaglutide Weight Loss Below Trial Levels | Real-World Semaglutide Weight Loss Below Trial Levels | | Real-World Semaglutide Weight Loss Below Trial Levels | | Real-World Semaglutide Weight Loss Below Trial Levels | | Real-World Semaglutide Weight Loss Below Trial Levels |

NEWSHEALTH : Real-World Semaglutide Weight Loss Below Trial Levels